UPDATE -- Trado GmbH Announces That Berlin Court Intervenes and Grants Preliminary Injunction Against Matthias Woestmann and Associates, Who Lost Millions of Envion Investor Money
Trado GmbH / UPDATE -- Trado GmbH Announces That Berlin Court Intervenes and Grants Preliminary Injunction Against Matthias Woestmann and Associates, Who Lost Millions of Envion Investor Money . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement.
Victory for Envion Founders, As Quadrat Capital and Sycamore GmbH, Controlled by Woestmann, Thomas van Aubel, and Jutta Freifrau von Falkenhausen, Receive Setback
BERLIN, June 07, 2018 (GLOBE NEWSWIRE) -- The following are statements issued by Trado GmbH: Matthias Woestmann and his business associates, through their investment vehicles Quadrat Capital and Sycamore GmbH, received a striking blow on Tuesday from a Berlin judge in a ruling that may be the first of many setbacks for the current majority owners of Swiss blockchain infrastructure company envion AG. A preliminary injunction filed on behalf of envion's founders - led by Michael Luckow through the founders' company Trado GmbH - who claim rightful ownership of envion, was granted on Tuesday, June 5th, 2018.
Actions taken by Woestmann and the others follow a pattern used with previous companies involved in scandals across Germany. Evidence seen by the Berlin court was sufficient for the judge to rule that envion shares cannot be sold or traded to any 3rd party. The ruling further forbids envion's unlawful shareholders from transferring or debiting any of envion's assets. Envion's founders have stated that they will continue to file lawsuits in both German and Swiss courts until their majority is restored. The next court date is scheduled for June 21st.
The owners of the two holding companies (Quadrat Capital GmbH and Sycamore GmbH), Matthias Woestmann, Thomas van Aubel, Jutta Freifrau von Falkenhausen, and Dinnies von der Osten, have a history of profiting from investments in companies that fail spectacularly and under suspicious circumstances. They and their associates are linked to a long list of companies involved in some of Germany's largest financial scandals, including IGB, Balda (renamed to Clere), Q-cells, and Solon.
Mistakes made while executing the takeover of envion, which raised $100 million in an ICO in January, may keep envion from being their latest victim. Instead of a legal corporate takeover, Woestmann violated a contract which explicitly forbade him from actions compromising the majority ownership of the founders. Woestmann's inaction since the takeover has resulted in millions of dollars in lost dividends for investors and the founders being blocked from operating the company.
"Woestmann's serious missteps now threaten to bring his and his confederates' house of cards crashing down because he illegally created extra shares via an unauthorized capital increase which he then gave to Sycamore," said Michael Luckow, one of the founders of envion who have taken legal action against Woestmann and his associates.
Speaking to Swiss news service SWI, Woestmann did not deny charges that his actions were illegal when he diluted the founders' shares. Envion investors reported that he admitted his guilt in a call on May 28th which was widely discussed within the envion investor community, stating that he expected that he would be found guilty and would be liable for damages.
When solicitations distributed by Woestmann for bids to buy envion were attained by the founders, they moved quickly to file the court injunction. Documents show Woestmann attempting to sell envion for use as a "holding structure for new businesses to separate envion (sic) balance sheet from profitable businesses" and advertising that the "existing investor base can be used for all kinds of [other] business models" apart from the business that investors supported with $100 million.
About Trado GmbH
Trado GmbH holds the founders' shares in envion AG, a German-Swiss company that has developed a disruptive datacenter concept for crypto mining: a system of container-based mobile units that can be deployed right at the source of energy, either at the solar photovoltaic (PV) park or the power plant, providing the required flexibility for today's energy markets. Information about Trado and envion's founders can be found at www.envion-founders.org.
Chris Pfaff Tech Media LLC
NAÏMA Strategic Legal Services GmbH
phone: +49 30 2404 8290
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Trado GmbH via Globenewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
Corline Biomedical AB presenterar på Redeyes Growth Day 202026.5.2020 13:54:48 CEST | Pressemelding
Den 2 juni kl 14.00 presenterar Henrik Nittmar, VD i Corline Biomedical AB den senaste utvecklingen i bolaget på Redeye. Presentationen livesänds och kan följas på https://www.redeye.se/live/growth-day-2020 där presentationen även i efterhand kommer finnas tillgänglig, samt på vår bolagssida i Redeye Universe https://www.redeye.se/company/corline-biomedical. För mer information, vänligen kontakta Henrik Nittmar, VD Telefon: 018-71 30 90 E-post: firstname.lastname@example.org Certified Adviser Svensk Kapitalmarknadsgranskning Telefon: 011-32 30 732 E-post: email@example.com Corline Biomedical AB arbetar med den kroppsegna substansen heparin och har utvecklat en portfölj med läkemedelskandidater för användning i anslutning till organ- och celltransplantation. Bolaget planerar kliniska studier inom diabetes typ 1 och njurtransplantation, för vilket Corline även har erhållit särläkemedelsstatus (”Orphan Drug”). Inom ramen för helägda dotterbolaget Corline Pharma AB utvärderas in vivo-administrati
Corline Biomedical AB presenterar på Redeyes Temaevent Orphan Drugs26.5.2020 13:49:07 CEST | Pressemelding
Corline Biomedical AB (”Corline”) kommer att presentera sin verksamhet på Redeyes temaevent Orphan Drugs. Presentationen sker kl 11:30 den 27 maj 2020 i Stockholm och livesänds via Redeyes hemsida. Konferensprogrammet och livesändningen görs tillgängliga via Redeyes hemsida https://www.redeye.se/live/orphan-27-maj. För mer information, vänligen kontakta Henrik Nittmar, VD Telefon: 018-71 30 90 E-post: firstname.lastname@example.org Certified Adviser Svensk Kapitalmarknadsgranskning Telefon: 011-32 30 732 E-post: email@example.com Corline Biomedical AB arbetar med den kroppsegna substansen heparin och har utvecklat en portfölj med läkemedelskandidater för användning i anslutning till organ- och celltransplantation. Bolaget planerar kliniska studier inom diabetes typ 1 och njurtransplantation, för vilket Corline även har erhållit särläkemedelsstatus (”Orphan Drug”). Inom ramen för helägda dotterbolaget Corline Pharma AB utvärderas in vivo-administration av Corlines heparinsubstans och sedan tidigare
Lundin Gold Inc. Announces C$50 Million Bought Deal Financing26.5.2020 13:30:02 CEST | Press release
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION TO UNITED STATES VANCOUVER, British Columbia, May 26, 2020 (GLOBE NEWSWIRE) -- Lundin Gold Inc. ("Lundin Gold" or the "Company") (TSX: LUG, Nasdaq Stockholm: LUG) has announced today that it has entered into an agreement with BMO Capital Markets (“BMO”), under which BMO has agreed to buy on a bought deal basis 4,150,000 common shares (the “Common Shares”), at a price of C$12.05 per Common Share for gross proceeds of approximately C$50 million (the “Offering”). The Company has granted BMO an option, exercisable at the offering price for a period of 30 days following the closing of the Offering, to purchase up to an additional 15% of the Offering to cover over-allotments, if any. The offering is expected to close on or about June 11, 2020 and is subject to Lundin Gold receiving all necessary regulatory approvals. Newcrest Mining Limited, which currently holds approximately 32% of the Company’s issued and outsta
PCI Biotech: Disclosure of voting rights for Chairman of the Board26.5.2020 13:20:03 CEST | Press release
Oslo, 26 May 2020. PCI Biotech Holding ASA ("PCI Biotech" or the "Company") issue this notification on behalf of its chairman, Hans Peter Bøhn. Hans Peter Bøhn is chairman of PCI Biotech and shall open the annual general meeting of the Company on 27 May 2020. Mr. Bøhn holds 123,662 shares, representing 0.3 per cent of the share capital of PCI Biotech. Mr. Bøhn has received powers of attorney to represent and vote for 7,171,710 additional shares. In total, Mr. Bøhn will represent and vote for 19.6 per cent of the share capital. A major part of the powers of attorney are without voting instructions. The powers of attorney are only valid at the annual general meeting on 27 May 2020. This information is subject to the disclosure requirements pursuant to section 4 -3, cf. section 5-12 of the Norwegian Securities Trading Act. Contact information: PCI Biotech Holding ASA, Ullernchausséen 64, N-0379 Oslo Ronny Skuggedal, CFO, firstname.lastname@example.org, Mobile: +47 9400 5757
Prosafe SE: First quarter 2020 report – Adapting to a new reality26.5.2020 11:44:38 CEST | Press release
(Figures in brackets refer to the corresponding period of 2019) After several years of low activity across the industry, the company has presented a business plan and a restructuring proposal to lenders which – if approved as proposed – will result in a sustainable balance sheet. The revised business plan reflects a new reality in light of Covid-19, structural changes, oil price collapse, oversupply and anticipated impact on future activity and performance. Consequently, an impairment of USD 810.5 million was made to the book value of vessels in the quarter resulting in a negative book equity of USD 858.9 million by the end of the quarter. The company has sufficient liquidity of USD 184 million at the end of the quarter and continues to operate on a going concern basis on the assumption that there is justified hope to agree a sustainable financial solution with lenders. Recent highlights Prosafe implemented Covid-19 plans early to safeguard people and assets, and this has proven succes
Result of Riksbank reversed auctions SEK Municipal Bonds26.5.2020 11:30:00 CEST | Press release
Result of Riksbank reversed auctions SEK Municipal Bonds Results of auctions Municipal BondsAggregateAuction date5/26/2020Maturity2022Tendered volume, mln SEK750 +/- 750Volume offered, mln SEK1,600Volume bought, mln SEK100Number of bids4Number of accepted bids1Credit Class 1Maturity, QuarterQ1Maturity, QuarterQ2Maturity, QuarterQ3Maturity, QuarterQ4Volume Offered, mln SEK0Volume Offered, mln SEK0Volume Offered, mln SEK0Volume Offered, mln SEK0Volume bought, mln SEK0Volume bought, mln SEK0Volume bought, mln SEK0Volume bought, mln SEK0Number of bids0Number of bids0Number of bids0Number of bids0Number of accepted bids0Number of accepted bids0Number of accepted bids0Number of accepted bids0Average yield-Average yield-Average yield-Average yield-Lowest accepted yield-Lowest accepted yield-Lowest accepted yield-Lowest accepted yield-Highest yield-Highest yield-Highest yield-Highest yield-% accepted at lowest yield-% accepted at lowest yield-% accepted at lowest yield-% accepted at lowest yie